United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - microgestin and microgestin fe are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease - known or suspected carcinoma of the breast - carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia - undiagnosed abnormal genital bleeding - cholestatic jaundice of pregnancy or jaundice with prior pill u

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - microgestin fe 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: ● thrombophlebitis or thromboembolic disorders ● a past history of deep vein thrombophlebitis or thromboembolic disorders ● cerebral vascular or coronary artery disease ● known or suspected carcinoma of the breast ● carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia ● undiagnosed abnormal genital bleeding ● cholestatic jaundice of pregnancy or jaundice with prior pill use ● hepatic

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - microgestin 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: ● thrombophlebitis or thromboembolic disorders ● a past history of deep vein thrombophlebitis or thromboembolic disorders ● cerebral vascular or coronary artery disease ● known or suspected carcinoma of the breast ● carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia ● undiagnosed abnormal genital bleeding ● cholestatic jaundice of pregnancy or jaundice with prior pill use ● hepatic ad

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - microgestin fe 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: ● thrombophlebitis or thromboembolic disorders ● a past history of deep vein thrombophlebitis or thromboembolic disorders ● cerebral vascular or coronary artery disease ● known or suspected carcinoma of the breast ● carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia ● undiagnosed abnormal genital bleeding ● cholestatic jaundice of pregnancy or jaundice with prior pill use ● hepat

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - microgestin 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: ● thrombophlebitis or thromboembolic disorders ● a past history of deep vein thrombophlebitis or thromboembolic disorders ● cerebral vascular or coronary artery disease ● known or suspected carcinoma of the breast ● carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia ● undiagnosed abnormal genital bleeding ● cholestatic jaundice of pregnancy or jaundice with prior pill use ● hepatic

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - microgestin fe 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: ● thrombophlebitis or thromboembolic disorders ● a past history of deep vein thrombophlebitis or thromboembolic disorders ● cerebral vascular or coronary artery disease ● known or suspected carcinoma of the breast ● carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia ● undiagnosed abnormal genital bleeding ● cholestatic jaundice of pregnancy or jaundice with prior pill use ● hepatic

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

micro -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

micro -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

micro -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

micro -